PMID: 8603019Feb 1, 1996Paper

Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

British Journal of Haematology
M I BokarewaM Blombäck

Abstract

Seventy women with thrombosis in pregnancy were investigated for the presence of APC resistance and the associated Arg506-Gln mutation in coagulation factor V. The mutation was found in 46% of the investigated women. Carriers of the mutation were more prone to develop thrombosis in the first pregnancy (OR (odds ratio) = 3.41; P < 0.05) and had a higher probability of recurrence (OR = 3.86; P < 0.05) compared to non-carriers. The incidence of miscarriage was not related to the mutation but its probability increased in women with thrombosis in a second or subsequent pregnancy (P < 0.025). Negative dynamics of APC response during pregnancy was observed in 20/22 women; eight of them developed APC resistance de novo. The suppression of APC response was independent of the mutation.

Citations

Jul 9, 2003·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·W DongM Lin
May 21, 2013·Archives of Gynecology and Obstetrics·Farah ParveenSuraksha Agrawal
Oct 1, 1996·The American Journal of Medicine·G A OttersonF J Kaye
Feb 20, 2003·Thrombosis Research·Shannon M Bates
Mar 27, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M BozzoG Pardi
Sep 27, 2000·Hematology/oncology Clinics of North America·L HeilmannG F von Tempelhoff
May 24, 2003·Best Practice & Research. Clinical Haematology·Katarina A Bremme
May 24, 2003·Best Practice & Research. Clinical Haematology·Rainer B ZotzRüdiger E Scharf
Nov 8, 2002·Acta Obstetricia Et Gynecologica Scandinavica·Chiara BenedettoAntonella Curti
May 8, 1999·British Journal of Haematology·Z R HolmesH Cohen
Apr 29, 1998·Current Opinion in Obstetrics & Gynecology·J Girling, M de Swiet
Feb 16, 2000·Obstetrical & Gynecological Survey·R B Gherman, T M Goodwin
Oct 19, 2000·Journal of Pediatric Hematology/oncology·K J BroxtermanL Chicoine
Jul 17, 1999·Current Opinion in Pulmonary Medicine·M D McCollI A Greer
Nov 4, 1998·British Journal of Obstetrics and Gynaecology·A M Cumming, R C Tait
Aug 24, 1999·British Journal of Obstetrics and Gynaecology·M D McCollI A Greer
Apr 12, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·M D McCollI A Greer
Jun 18, 2002·Journal of Cellular and Molecular Medicine·Lucia M. ProcopciucGh. Jebeleanu
Sep 26, 2000·Journal of Clinical Pathology·I D Walker
Apr 25, 2000·Annual Review of Medicine·C KearonJ Hirsh
Apr 21, 1999·Lancet·F R Rosendaal
Mar 1, 2007·Women's Health·Rainer B ZotzRüdiger E Scharf
Aug 4, 2004·British Journal of Haematology·Jody L Kujovich
Jan 19, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·M Knight, UNKNOWN UKOSS
Aug 3, 2006·Journal of Thrombosis and Haemostasis : JTH·P G Lindqvist, J Carlson
Aug 5, 2000·American Heart Journal·D A MajorD M Herrington
Mar 31, 1999·Baillière's Clinical Haematology·A Greinacher
May 20, 1999·Baillière's Clinical Haematology·G F Pineo, R D Hull
Mar 7, 1998·Baillière's Clinical Obstetrics and Gynaecology·I D Walker
Aug 2, 2001·Best Practice & Research. Clinical Obstetrics & Gynaecology·I A Greer, A J Thomson
Feb 1, 1997·American Journal of Obstetrics and Gynecology·C LindoffB Astedt
Apr 11, 2003·Clinics in Chest Medicine·Ian A Greer
Jul 4, 2007·Expert Review of Cardiovascular Therapy·Mrinal M PatnaikColleen T Morton
Jul 18, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·R L Bick
Jan 29, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Rodger L Bick, Debra Hoppensteadt
Feb 7, 2001·Stroke; a Journal of Cerebral Circulation·M J KupfermincA Eldor
Jun 18, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·David M HerringtonStephen B Hulley
Jul 16, 2019·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Katarina BremmeRoza Chaireti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.